These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 24956560

  • 1. Association of PARP-1, NF-κB, NF-κBIA and IL-6, IL-1β and TNF-α with Graves Disease and Graves Ophthalmopathy.
    Niyazoglu M, Baykara O, Koc A, Aydoğdu P, Onaran I, Dellal FD, Tasan E, Sultuybek GK.
    Gene; 2014 Sep 01; 547(2):226-32. PubMed ID: 24956560
    [Abstract] [Full Text] [Related]

  • 2. Poly (ADP-ribose) polymerase-1 (PARP-1) in Chinese patients with Graves' disease and Graves' ophthalmopathy.
    Wu T, Tang DR, Zhao L, Sun FY.
    Can J Physiol Pharmacol; 2018 Jun 01; 96(6):556-561. PubMed ID: 28177666
    [Abstract] [Full Text] [Related]

  • 3. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population.
    Koc A, Batar B, Celik O, Onaran I, Tasan E, Sultuybek GK.
    Immunobiology; 2014 Jul 01; 219(7):531-6. PubMed ID: 24703107
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Graves' ophthalmopathy and gene polymorphisms in interleukin-1alpha, interleukin-1beta, interleukin-1 receptor and interleukin-1 receptor antagonist.
    Khalilzadeh O, Anvari M, Esteghamati A, Mahmoudi M, Tahvildari M, Rashidi A, Khosravi F, Amirzargar A.
    Clin Exp Ophthalmol; 2009 Aug 01; 37(6):614-9. PubMed ID: 19702713
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes.
    Anvari M, Khalilzadeh O, Esteghamati A, Esfahani SA, Rashidi A, Etemadi A, Mahmoudi M, Amirzargar AA.
    Eye (Lond); 2010 Jun 01; 24(6):1058-63. PubMed ID: 19798110
    [Abstract] [Full Text] [Related]

  • 9. Tumor necrosis factor-α and interleukin-1β gene polymorphisms and risk of brain abscess in North Indian population.
    Mishra P, Prasad KN, Singh K, Bajpai A, Sahu RN, Ojha BK.
    Cytokine; 2015 Sep 01; 75(1):159-64. PubMed ID: 26187330
    [Abstract] [Full Text] [Related]

  • 10. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X, Latif R, Bahn R, Tomer Y, Davies TF.
    Thyroid; 2008 Nov 01; 18(11):1201-6. PubMed ID: 18925838
    [Abstract] [Full Text] [Related]

  • 11. The VDR gene confers a genetic predisposition to Graves' disease and Graves' ophthalmopathy in the Southwest Chinese Han population.
    Zhou F, Liang Z, Wang X, Tan G, Wei W, Zheng G, Ma X, Tian D, Li H, Yu H.
    Gene; 2021 Aug 15; 793():145750. PubMed ID: 34077777
    [Abstract] [Full Text] [Related]

  • 12. Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy.
    van Steensel L, Paridaens D, Dingjan GM, van Daele PL, van Hagen PM, Kuijpers RW, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA.
    Invest Ophthalmol Vis Sci; 2010 Feb 15; 51(2):1002-7. PubMed ID: 19797221
    [Abstract] [Full Text] [Related]

  • 13. Association between interleukin 21 and Graves' disease.
    Jia HY, Zhang ZG, Gu XJ, Guo T, Cui B, Ning G, Zhao YJ.
    Genet Mol Res; 2011 Oct 31; 10(4):3338-46. PubMed ID: 22057994
    [Abstract] [Full Text] [Related]

  • 14. Role of poly (ADP-ribose) polymerase-1 and cytokines in acute renal injury in elderly Chinese patients with diabetes mellitus.
    Cao L, Liu Y, Zhang L, Wei Y.
    Clin Interv Aging; 2017 Oct 31; 12():2039-2045. PubMed ID: 29238179
    [Abstract] [Full Text] [Related]

  • 15. Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone.
    Antonelli A, Ferrari SM, Fallahi P, Piaggi S, Paolicchi A, Franceschini SS, Salvi M, Ferrannini E.
    Metabolism; 2011 Feb 31; 60(2):277-83. PubMed ID: 20206950
    [Abstract] [Full Text] [Related]

  • 16. TNFSF15 Polymorphisms are Associated with Graves' Disease and Graves' Ophthalmopathy in a Han Chinese Population.
    Zhang M, Liu S, Xu J, Lv S, Fan Y, Zhang Y, Zhang Y, Wu Y, Su Y, Yu H, Song S, He J, Li H.
    Curr Eye Res; 2020 Jul 31; 45(7):888-895. PubMed ID: 31869260
    [Abstract] [Full Text] [Related]

  • 17. Predisposition to Graves' disease and Graves' ophthalmopathy by genetic variants of IL2RA.
    Du J, Wang X, Tan G, Wei W, Zhou F, Liang Z, Li H, Yu H.
    J Mol Med (Berl); 2021 Oct 31; 99(10):1487-1495. PubMed ID: 34287665
    [Abstract] [Full Text] [Related]

  • 18. Poly(ADP-ribose) polymerase 1 inhibition prevents interleukin-1β-induced inflammation in human osteoarthritic chondrocytes.
    Sun Y, Zhou L, Lv D, Liu H, He T, Wang X.
    Acta Biochim Biophys Sin (Shanghai); 2015 Jun 31; 47(6):422-30. PubMed ID: 25926140
    [Abstract] [Full Text] [Related]

  • 19. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
    Daroszewski J, Pawlak E, Karabon L, Frydecka I, Jonkisz A, Slowik M, Bolanowski M.
    Eur J Endocrinol; 2009 Nov 31; 161(5):787-93. PubMed ID: 19734241
    [Abstract] [Full Text] [Related]

  • 20. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.
    Kurylowicz A, Hiromatsu Y, Jurecka-Lubieniecka B, Kula D, Kowalska M, Ichimura M, Koga H, Kaku H, Bar-Andziak E, Nauman J, Jarzab B, Ploski R, Bednarczuk T.
    Genes Immun; 2007 Oct 31; 8(7):532-8. PubMed ID: 17690684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.